• Home
  • The Team
  • Education Series
    • Immunotherapy
    • Adverse Events
    • Biomarkers
  • Sharing Journeys
    • Thrivers
    • Researchers
    • Nurses
    • Investors
    • Innovative Companies
  • Clinical Trials
  • Events
  • Proud Partnerships
  • More
    • Home
    • The Team
    • Education Series
      • Immunotherapy
      • Adverse Events
      • Biomarkers
    • Sharing Journeys
      • Thrivers
      • Researchers
      • Nurses
      • Investors
      • Innovative Companies
    • Clinical Trials
    • Events
    • Proud Partnerships
  • Home
  • The Team
  • Education Series
    • Immunotherapy
    • Adverse Events
    • Biomarkers
  • Sharing Journeys
    • Thrivers
    • Researchers
    • Nurses
    • Investors
    • Innovative Companies
  • Clinical Trials
  • Events
  • Proud Partnerships

WHAT ARE BIOMARKERS?

Biomarkers in cancer are substances or processes measurable in the body that provide crucial information about the cancer’s presence, type, or progression. They are essential for diagnosing and managing cancer. Here are some key points about cancer biomarkers:


Types of Biomarkers:

  • Diagnostic Biomarkers: Help detect cancer in the body before symptoms appear.
  • Prognostic Biomarkers: Offer information about a patient’s overall outcome, regardless of treatment.
  • Predictive Biomarkers: Indicate the likely benefit of a therapeutic intervention, assisting in treatment selection.


Sources and Detection:

  • Biomarkers can be found in blood, tissue, urine, or other body fluids.
  • They are commonly measured through blood tests, biopsies, or imaging techniques.


Examples:

  • Prostate-specific antigen (PSA): Used for diagnosing and monitoring prostate cancer.
  • HER2/neu protein: Indicates a specific type of breast cancer and predicts response to targeted therapy.
  • BRAF V600E mutation: Found in various cancers, including melanoma, and indicates response to certain targeted therapies.


Roles and Benefits:

  • Biomarkers enable early detection and more precise treatment, improving survival rates.
  • They assist in monitoring treatment response and detecting recurrence.


Research in this area continues to advance, aiming to develop new biomarkers for more personalized cancer care.

Copyright © 2024 Dr. Roy's Cancer Journey - All Rights Reserved.


Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept